BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 27365148)

  • 1. How does adenosine control neuronal dysfunction and neurodegeneration?
    Cunha RA
    J Neurochem; 2016 Dec; 139(6):1019-1055. PubMed ID: 27365148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticity.
    Cunha RA
    Neurochem Int; 2008 Jan; 52(1-2):65-72. PubMed ID: 17664029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
    Abbracchio MP; Cattabeni F
    Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ATP release and CD73-mediated adenosine A
    Augusto E; Gonçalves FQ; Real JE; Silva HB; Pochmann D; Silva TS; Matos M; Gonçalves N; Tomé ÂR; Chen JF; Canas PM; Cunha RA
    Neurobiol Dis; 2021 Sep; 157():105441. PubMed ID: 34224862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
    Gomes CV; Kaster MP; Tomé AR; Agostinho PM; Cunha RA
    Biochim Biophys Acta; 2011 May; 1808(5):1380-99. PubMed ID: 21145878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adenosine neuromodulation system in schizophrenia.
    Rial D; Lara DR; Cunha RA
    Int Rev Neurobiol; 2014; 119():395-449. PubMed ID: 25175974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purinergic regulation of acetylcholine release.
    Ribeiro JA; Cunha RA; Correia-de-Sá P; Sebastião AM
    Prog Brain Res; 1996; 109():231-41. PubMed ID: 9009712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal GABAergic transmission: a new target for adenosine control of excitability.
    Rombo DM; Ribeiro JA; Sebastião AM
    J Neurochem; 2016 Dec; 139(6):1056-1070. PubMed ID: 27778347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.
    Stone TW; Ceruti S; Abbracchio MP
    Handb Exp Pharmacol; 2009; (193):535-87. PubMed ID: 19639293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroprotective mechanisms of adenosine action on CNS neurons].
    Zalewska-Kaszubska J
    Neurol Neurochir Pol; 2002; 36(2):329-36. PubMed ID: 12046508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purines and neuroprotection.
    Stone TW
    Adv Exp Med Biol; 2002; 513():249-80. PubMed ID: 12575824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal Adenosine A2A Receptors Are Critical Mediators of Neurodegeneration Triggered by Convulsions.
    Canas PM; Porciúncula LO; Simões AP; Augusto E; Silva HB; Machado NJ; Gonçalves N; Alfaro TM; Gonçalves FQ; Araújo IM; Real JI; Coelho JE; Andrade GM; Almeida RD; Chen JF; Köfalvi A; Agostinho P; Cunha RA
    eNeuro; 2018; 5(6):. PubMed ID: 30627646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation and metamodulation of synapses by adenosine.
    Ribeiro JA; Sebastião AM
    Acta Physiol (Oxf); 2010 Jun; 199(2):161-9. PubMed ID: 20345418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A
    Reis SL; Silva HB; Almeida M; Cunha RA; Simões AP; Canas PM
    J Neurochem; 2019 Oct; 151(2):227-237. PubMed ID: 31274188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors.
    Pugliese AM; Latini S; Corradetti R; Pedata F
    Br J Pharmacol; 2003 Sep; 140(2):305-14. PubMed ID: 12970092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A
    Moreira-de-Sá A; Lourenço VS; Canas PM; Cunha RA
    Front Neurosci; 2021; 15():702581. PubMed ID: 34335174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine receptors co-operate with NMDA preconditioning to protect cerebellar granule cells against glutamate neurotoxicity.
    Boeck CR; Kroth EH; Bronzatto MJ; Vendite D
    Neuropharmacology; 2005 Jul; 49(1):17-24. PubMed ID: 15992577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptic mechanisms of adenosine A2A receptor-mediated hyperexcitability in the hippocampus.
    Rombo DM; Newton K; Nissen W; Badurek S; Horn JM; Minichiello L; Jefferys JG; Sebastiao AM; Lamsa KP
    Hippocampus; 2015 May; 25(5):566-80. PubMed ID: 25402014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular distributions of adenosine A1 and A2A receptors in the rat dorsomedial nucleus of the solitary tract at the level of the area postrema.
    Pickel VM; Chan J; Linden J; Rosin DL
    Synapse; 2006 Dec; 60(7):496-509. PubMed ID: 16952160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.